P. Pere, L. Lindgren, M. Vaara
Sep 1, 1999
Citations
1
Influential Citations
50
Citations
Journal
Anesthesiology
Abstract
ROPIVACAINE (1-propyl-29,69-pipecoloxylidide) is a long-acting aminoamide local anesthetic that has been introduced into clinical use in the last few years, largely as a replacement for bupivacaine. Bupivacaine has been reported to possess a significant antibacterial effect. Because data regarding ropivacaine are not available, we compared the antibacterial effects of clinically appropriate concentrations of ropivacaine and bupivacaine in a laboratory setting.